-
1
-
-
0037418546
-
Management of the clinically inapparent adrenal mass ('incidentaloma')
-
Grumbach MM, Biller BM, Braunstein GD et al. Management of the clinically inapparent adrenal mass ('incidentaloma'). Ann. Intern. Med. 2003; 138; 424-429.
-
(2003)
Ann. Intern. Med.
, vol.138
, pp. 424-429
-
-
Grumbach, M.M.1
Biller, B.M.2
Braunstein, G.D.3
-
2
-
-
0034917097
-
Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group
-
Icard P, Goudet P, Charpenay C et al. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J. Surg. 2001; 25; 891-897.
-
(2001)
World J. Surg.
, vol.25
, pp. 891-897
-
-
Icard, P.1
Goudet, P.2
Charpenay, C.3
-
4
-
-
0034651712
-
Adrenocortical carcinoma: clinical and laboratory observations
-
Wajchenberg BL, Albergaria Pereira MA, Medonca BB et al. Adrenocortical carcinoma: clinical and laboratory observations. Cancer 2000; 88; 711-736.
-
(2000)
Cancer
, vol.88
, pp. 711-736
-
-
Wajchenberg, B.L.1
Albergaria Pereira, M.A.2
Medonca, B.B.3
-
5
-
-
0021350092
-
Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors
-
Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am. J. Surg. Pathol. 1984; 8; 163-169.
-
(1984)
Am. J. Surg. Pathol.
, vol.8
, pp. 163-169
-
-
Weiss, L.M.1
-
6
-
-
0024513504
-
Pathologic features of prognostic significance in adrenocortical carcinoma
-
Weiss LM, Medeiros LJ, Vickery AL Jr. Pathologic features of prognostic significance in adrenocortical carcinoma. Am. J. Surg. Pathol. 1989; 13; 202-206.
-
(1989)
Am. J. Surg. Pathol.
, vol.13
, pp. 202-206
-
-
Weiss, L.M.1
Medeiros, L.J.2
Vickery Jr, A.L.3
-
7
-
-
0036892571
-
Weiss system revisited: a clinicopathological and immunohistochemical study of 49 adrenocortical tumors
-
Aubert S, Wacrenier A, Leroy X et al. Weiss system revisited: a clinicopathological and immunohistochemical study of 49 adrenocortical tumors. Am. J. Surg. Pathol. 2002; 26; 1612-1619.
-
(2002)
Am. J. Surg. Pathol.
, vol.26
, pp. 1612-1619
-
-
Aubert, S.1
Wacrenier, A.2
Leroy, X.3
-
8
-
-
0035884186
-
Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors
-
Gicquel C, Bertagna X, Gaston V et al. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res. 2001; 61; 6762-6767.
-
(2001)
Cancer Res.
, vol.61
, pp. 6762-6767
-
-
Gicquel, C.1
Bertagna, X.2
Gaston, V.3
-
9
-
-
0037984421
-
Adrenocortical tumors: results of treatment and study of Weiss's score as a prognostic factor
-
Lucon AM, Pereira MA, Mendonca BB et al. Adrenocortical tumors: results of treatment and study of Weiss's score as a prognostic factor. Rev. Hosp. Clin. Fac. Med. São Paulo 2002; 57; 251-256.
-
(2002)
Rev. Hosp. Clin. Fac. Med. São Paulo
, vol.57
, pp. 251-256
-
-
Lucon, A.M.1
Pereira, M.A.2
Mendonca, B.B.3
-
10
-
-
33751228143
-
Case records of the Massachusetts General Hospital. Case 36-2006. A 35-year-old pregnant woman with new hypertension
-
Klibanski A, Stephen AE, Greene MF et al. Case records of the Massachusetts General Hospital. Case 36-2006. A 35-year-old pregnant woman with new hypertension. N. Engl. J. Med. 2006; 355; 2237-2245.
-
(2006)
N. Engl. J. Med.
, vol.355
, pp. 2237-2245
-
-
Klibanski, A.1
Stephen, A.E.2
Greene, M.F.3
-
11
-
-
4544345013
-
Does tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors?
-
Pohlink C, Tannapfe A, Eichfeld U et al. Does tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors? J. Endocrinol. Invest. 2004; 27; 565-569.
-
(2004)
J. Endocrinol. Invest.
, vol.27
, pp. 565-569
-
-
Pohlink, C.1
Tannapfe, A.2
Eichfeld, U.3
-
12
-
-
0038343499
-
MicroRNA pathways in flies and worms: growth, death, fat stress, and timing
-
Ambros V. MicroRNA pathways in flies and worms: growth, death, fat stress, and timing. Cell 2003; 113; 673-676.
-
(2003)
Cell
, vol.113
, pp. 673-676
-
-
Ambros, V.1
-
13
-
-
77951048682
-
Oncogene role of Mir-483-3p at IGF2/483 locus
-
Veronese A, Lupini L, Consiglio J et al. Oncogene role of Mir-483-3p at IGF2/483 locus. Cancer Res. 2010; 70; 3140-3149.
-
(2010)
Cancer Res.
, vol.70
, pp. 3140-3149
-
-
Veronese, A.1
Lupini, L.2
Consiglio, J.3
-
15
-
-
78650856849
-
MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer
-
Hao J, Zhang S, Zhou Y et al. MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. FEBS Lett. 2011; 585; 207-213.
-
(2011)
FEBS Lett.
, vol.585
, pp. 207-213
-
-
Hao, J.1
Zhang, S.2
Zhou, Y.3
-
16
-
-
0037331277
-
Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis
-
Giordano TJ, Thomas DG, Kuick R et al. Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am. J. Pathol. 2003; 162; 521-531.
-
(2003)
Am. J. Pathol.
, vol.162
, pp. 521-531
-
-
Giordano, T.J.1
Thomas, D.G.2
Kuick, R.3
-
17
-
-
20144386848
-
Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy
-
de Fraipont F, El Atifi M, Cherradi N et al. Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy. J. Clin. Endocrinol. Metab. 2005; 90; 1819-1829.
-
(2005)
J. Clin. Endocrinol. Metab.
, vol.90
, pp. 1819-1829
-
-
de Fraipont, F.1
El Atifi, M.2
Cherradi, N.3
-
18
-
-
57049090610
-
MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival
-
Dillhoff M, Liu J, Frankel W, Croce C, Bloomston M. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J. Gastrointest. Surg. 2008; 12; 2171-2176.
-
(2008)
J. Gastrointest. Surg.
, vol.12
, pp. 2171-2176
-
-
Dillhoff, M.1
Liu, J.2
Frankel, W.3
Croce, C.4
Bloomston, M.5
-
19
-
-
77956387978
-
MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets
-
Meyer-Rochow GY, Jackson NE, Conaglen JV et al. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets. Endocr. Relat. Cancer 2010; 17; 835-846.
-
(2010)
Endocr. Relat. Cancer
, vol.17
, pp. 835-846
-
-
Meyer-Rochow, G.Y.1
Jackson, N.E.2
Conaglen, J.V.3
-
20
-
-
67650480396
-
Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas
-
Soon PS, Gill AJ, Benn DE et al. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas. Endocr. Relat. Cancer 2009; 16; 573-583.
-
(2009)
Endocr. Relat. Cancer
, vol.16
, pp. 573-583
-
-
Soon, P.S.1
Gill, A.J.2
Benn, D.E.3
-
21
-
-
0033891752
-
Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation
-
Wilentz RE, Su GH, Dai JL et al. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation. Am. J. Pathol. 2000; 156; 37-43.
-
(2000)
Am. J. Pathol.
, vol.156
, pp. 37-43
-
-
Wilentz, R.E.1
Su, G.H.2
Dai, J.L.3
-
22
-
-
0034855810
-
Value of topoisomerase II alpha, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu immunohistochemical expression for the prediction of biologic behavior in adrenocortical neoplasms
-
Gupta D, Shidham V, Holden J et al. Value of topoisomerase II alpha, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu immunohistochemical expression for the prediction of biologic behavior in adrenocortical neoplasms. Appl. Immunohistochem. Mol. Morph. 2001; 9; 215-221.
-
(2001)
Appl. Immunohistochem. Mol. Morph.
, vol.9
, pp. 215-221
-
-
Gupta, D.1
Shidham, V.2
Holden, J.3
-
23
-
-
0032427744
-
Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms
-
Nakazumi H, Sasano H, Iino K et al. Expression of cell cycle inhibitor p27 and Ki-67 in human adrenocortical neoplasms. Mod. Pathol. 1998; 11; 1165-1170.
-
(1998)
Mod. Pathol.
, vol.11
, pp. 1165-1170
-
-
Nakazumi, H.1
Sasano, H.2
Iino, K.3
-
24
-
-
0034839753
-
Discerning malignancy in adrenocortical tumors: are molecular markers useful?
-
Wachenfeld C, Beuschlein F, Zwermann O et al. Discerning malignancy in adrenocortical tumors: are molecular markers useful? Eur. J. Endocrinol. 2001; 145; 335-341.
-
(2001)
Eur. J. Endocrinol.
, vol.145
, pp. 335-341
-
-
Wachenfeld, C.1
Beuschlein, F.2
Zwermann, O.3
-
25
-
-
33747404192
-
IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours
-
Schmitt A, Saremaslani P, Schmid S et al. IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours. Histopathology 2006; 49; 298-307.
-
(2006)
Histopathology
, vol.49
, pp. 298-307
-
-
Schmitt, A.1
Saremaslani, P.2
Schmid, S.3
-
26
-
-
0016372003
-
The clinical and pathologic features of 'non-hormonal' adrenocortical tumors: report of twenty new cases and review of the literature
-
Lewinsky BS, Grigor KM, Symington T, Neville AM. The clinical and pathologic features of 'non-hormonal' adrenocortical tumors: report of twenty new cases and review of the literature. Cancer 1974; 33; 778-790.
-
(1974)
Cancer
, vol.33
, pp. 778-790
-
-
Lewinsky, B.S.1
Grigor, K.M.2
Symington, T.3
Neville, A.M.4
-
27
-
-
0016501982
-
Adrenocortical neoplasms. Prognosis and morphology
-
Tang CK, Gray GF. Adrenocortical neoplasms. Prognosis and morphology. Urology 1975; 5; 691-695.
-
(1975)
Urology
, vol.5
, pp. 691-695
-
-
Tang, C.K.1
Gray, G.F.2
-
28
-
-
0027087416
-
Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery
-
Icard P, Chapuis Y, Andreassian B, Bernard A, Proye C. Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery. Surgery 1992; 6; 972-980.
-
(1992)
Surgery
, vol.6
, pp. 972-980
-
-
Icard, P.1
Chapuis, Y.2
Andreassian, B.3
Bernard, A.4
Proye, C.5
-
29
-
-
0033937670
-
Recent advances in surgical pathology of adrenal incidentaloma
-
Sasano H, Suzuki T, Moriya T. Recent advances in surgical pathology of adrenal incidentaloma. Biomed. Pharmacother. 2000; 54; 169-174.
-
(2000)
Biomed. Pharmacother.
, vol.54
, pp. 169-174
-
-
Sasano, H.1
Suzuki, T.2
Moriya, T.3
-
31
-
-
0026350931
-
Incidentally discovered adrenal tumors: an institutional perspective
-
Herrera MF, Grant CS, van Heerden JA, Sheedy PF, Ilstrup DM. Incidentally discovered adrenal tumors: an institutional perspective. Surgery 1991; 110; 1014-1021.
-
(1991)
Surgery
, vol.110
, pp. 1014-1021
-
-
Herrera, M.F.1
Grant, C.S.2
van Heerden, J.A.3
Sheedy, P.F.4
Ilstrup, D.M.5
-
32
-
-
34347364622
-
Molecular pathology of adrenal cortical tumors: separating adenomas from carcinomas
-
Giordano TJ. Molecular pathology of adrenal cortical tumors: separating adenomas from carcinomas. Endocr. Pathol. 2006; 17; 355-363.
-
(2006)
Endocr. Pathol.
, vol.17
, pp. 355-363
-
-
Giordano, T.J.1
-
33
-
-
79953767181
-
MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy
-
Patterson EE, Holloway AK, Weng J, Fojo T, Kebebew E. MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. Cancer 2011; 117; 1630-1639.
-
(2011)
Cancer
, vol.117
, pp. 1630-1639
-
-
Patterson, E.E.1
Holloway, A.K.2
Weng, J.3
Fojo, T.4
Kebebew, E.5
-
35
-
-
0032789933
-
Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line
-
Logié A, Boulle N, Gaston V et al. Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line. J. Mol. Endocrinol. 1999; 23; 23-32.
-
(1999)
J. Mol. Endocrinol.
, vol.23
, pp. 23-32
-
-
Logié, A.1
Boulle, N.2
Gaston, V.3
-
36
-
-
0030593038
-
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
-
Hahn SA, Schutte M, Hoque AT et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271; 350-353.
-
(1996)
Science
, vol.271
, pp. 350-353
-
-
Hahn, S.A.1
Schutte, M.2
Hoque, A.T.3
-
37
-
-
9044243025
-
Homozygous deletion map at 18q21.1 in pancreatic cancer
-
Hahn SA, Hoque AT, Moskaluk CA et al. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res. 1996; 56; 490-494.
-
(1996)
Cancer Res.
, vol.56
, pp. 490-494
-
-
Hahn, S.A.1
Hoque, A.T.2
Moskaluk, C.A.3
|